Report
Share
Download to read offline
Recommended
amgen Investors_2003_Proxy
This document is a letter from the Chairman, CEO and President of Amgen Inc. inviting shareholders to attend the company's upcoming Annual Meeting of Shareholders. The letter provides details on the meeting such as the date, time, location, and items of business to be voted on including electing directors, amending an equity incentive plan, ratifying an independent auditor, and a shareholder proposal. Shareholders are encouraged to vote by proxy in advance of the meeting.
bank of new york mellon corp 2q 07 earnings
The Bank of New York Mellon reported its second quarter 2007 earnings. Key highlights include:
- Revenue increased 19% to $3.2 billion driven by strong growth in asset management and securities servicing fees.
- Pre-tax income grew 28% to $1.1 billion as positive operating leverage led to a 34% pre-tax margin.
- The merger is achieving integration milestones and expense synergies are on track to reach $700 million by 2009.
- Combined assets under management were $1.1 trillion and assets under custody/administration were $20.4 trillion, demonstrating the company's strength in asset management and securities servicing.
amgen Investors_2001_AnnualReport
This document is Amgen's 2001 Annual Report. It discusses Amgen's financial performance in 2001 and key accomplishments. It launched two new products - Aranesp for anemia and Kineret for rheumatoid arthritis. It also received approval for Neulasta to help cancer patients undergoing chemotherapy. The report discusses advancements in research and development programs as well as organizational changes by adding new senior leadership. It affirmed Amgen's core values and emphasized continued commitment to patients, staff, and shareholders.
trw automotive holdings Proxy Statement 2005
The document is a proxy statement from TRW Automotive Holdings Corp. regarding its 2005 annual meeting of stockholders. It provides information on the date, time, and location of the meeting, as well as the two proposals to be voted on:
1) Election of three directors to three-year terms on the Board of Directors.
2) Ratification of Ernst & Young LLP as TRW's independent public accountants for 2005. Ernst & Young also served in this capacity in 2004.
The proxy statement provides background information on the proposals, director nominees, the company's board of directors and leadership, audit committee activities, executive compensation, and stock ownership. It seeks stockholders'
2006 Q3 TRW Auto Earnings Presentation
- TRW Automotive reported third quarter 2006 financial results with sales of $3.0 billion, up 3.4% from the prior year, but net earnings of only $5 million compared to $10 million in the previous year. The higher tax rate in the current quarter contributed significantly to the decrease in earnings.
- For the first nine months of 2006, TRW reported sales of $9.9 billion, up 3.8% from the same period in 2005. However, net earnings were $143 million compared to $145 million in 2005, impacted by non-recurring expenses related to debt retirement.
- TRW revised its full year 2006 guidance downward due to expected lower customer vehicle production and other
amgen Investors_2004_AnnualReport
The document is Amgen's 2004 annual report. It discusses Amgen's medicines for treating various medical conditions such as anemia, cancer, kidney disease, and immune disorders. It highlights key drugs such as EPOGEN, Aranesp, Neulasta, ENBREL, and Sensipar and provides examples of patients who have benefited from these treatments. The annual report also describes the science behind developing these drugs and advancing treatments.
Recommended
amgen Investors_2003_Proxy
This document is a letter from the Chairman, CEO and President of Amgen Inc. inviting shareholders to attend the company's upcoming Annual Meeting of Shareholders. The letter provides details on the meeting such as the date, time, location, and items of business to be voted on including electing directors, amending an equity incentive plan, ratifying an independent auditor, and a shareholder proposal. Shareholders are encouraged to vote by proxy in advance of the meeting.
bank of new york mellon corp 2q 07 earnings
The Bank of New York Mellon reported its second quarter 2007 earnings. Key highlights include:
- Revenue increased 19% to $3.2 billion driven by strong growth in asset management and securities servicing fees.
- Pre-tax income grew 28% to $1.1 billion as positive operating leverage led to a 34% pre-tax margin.
- The merger is achieving integration milestones and expense synergies are on track to reach $700 million by 2009.
- Combined assets under management were $1.1 trillion and assets under custody/administration were $20.4 trillion, demonstrating the company's strength in asset management and securities servicing.
amgen Investors_2001_AnnualReport
This document is Amgen's 2001 Annual Report. It discusses Amgen's financial performance in 2001 and key accomplishments. It launched two new products - Aranesp for anemia and Kineret for rheumatoid arthritis. It also received approval for Neulasta to help cancer patients undergoing chemotherapy. The report discusses advancements in research and development programs as well as organizational changes by adding new senior leadership. It affirmed Amgen's core values and emphasized continued commitment to patients, staff, and shareholders.
trw automotive holdings Proxy Statement 2005
The document is a proxy statement from TRW Automotive Holdings Corp. regarding its 2005 annual meeting of stockholders. It provides information on the date, time, and location of the meeting, as well as the two proposals to be voted on:
1) Election of three directors to three-year terms on the Board of Directors.
2) Ratification of Ernst & Young LLP as TRW's independent public accountants for 2005. Ernst & Young also served in this capacity in 2004.
The proxy statement provides background information on the proposals, director nominees, the company's board of directors and leadership, audit committee activities, executive compensation, and stock ownership. It seeks stockholders'
2006 Q3 TRW Auto Earnings Presentation
- TRW Automotive reported third quarter 2006 financial results with sales of $3.0 billion, up 3.4% from the prior year, but net earnings of only $5 million compared to $10 million in the previous year. The higher tax rate in the current quarter contributed significantly to the decrease in earnings.
- For the first nine months of 2006, TRW reported sales of $9.9 billion, up 3.8% from the same period in 2005. However, net earnings were $143 million compared to $145 million in 2005, impacted by non-recurring expenses related to debt retirement.
- TRW revised its full year 2006 guidance downward due to expected lower customer vehicle production and other
amgen Investors_2004_AnnualReport
The document is Amgen's 2004 annual report. It discusses Amgen's medicines for treating various medical conditions such as anemia, cancer, kidney disease, and immune disorders. It highlights key drugs such as EPOGEN, Aranesp, Neulasta, ENBREL, and Sensipar and provides examples of patients who have benefited from these treatments. The annual report also describes the science behind developing these drugs and advancing treatments.
amgen Investors_2003_AnnualReport
Amgen seeks to discover, develop, and commercialize proteins, antibodies, and small molecules to treat grievous illnesses through decades of scientific research. It pursues this mission through rigorous clinical testing of potential new therapeutics focused on areas like cancer, kidney disease, and neurodegenerative disorders. Amgen has extensive manufacturing operations worldwide to reliably supply its approved treatments to patients globally.
amgen Investors_2000_AnnualReport
This annual report summarizes Amgen's performance in 2000 and outlines goals for the future. Key points include:
- Amgen achieved strong financial results in 2000 and aims to more than double revenues and products on the market in the next five years.
- The company reaffirmed its commitment to its core values and adopted a shared aspiration to become the world's best human therapeutics company.
- Amgen hopes to launch four new products in the next 18 months, including ARANESP, anakinra, abarelix-depot, and SD/01, to treat conditions like anemia and cancer.
- The company expanded its R&D capabilities, grew its product pipeline, and plans to
amgen Investors_2002_AnnualReport
This annual report summarizes Amgen's performance and achievements in 2002. Some key points:
- Amgen served more patients than ever before and launched several new potential blockbuster products. It also delivered strong financial results.
- A major accomplishment was gaining FDA approval for its new ENBREL manufacturing facility in Rhode Island. This relieved a supply shortage and allowed more patients access to this important drug to treat rheumatoid arthritis.
- Amgen combined with Immunex Corporation, advancing scientific programs, bringing organizations together, and filling key roles. Construction also advanced on new research and manufacturing facilities.
- Despite significant growth, Amgen remained focused on its core values of being science-based, creating value for
2005 Q2 TRW Auto Earnings Presentation
TRW Automotive reported second quarter 2005 financial results. Key highlights include:
- Sales increased 6% to $3.4 billion compared to the prior year, driven by new product sales and currency effects.
- Net earnings were $85 million or $0.83 per share, which included a one-time $17 million tax benefit. Excluding this, earnings were $75 million or $0.73 per share.
- EBITDA was $324 million, roughly flat with the prior year after adjusting for restructuring charges.
- The company provided an updated outlook for 2005 with revenue of $12.5-12.9 billion and EPS of $1.60-1.80, excluding
amgen Investors_2005_AnnualReport
Dimitra, a 48-year-old mother of 3, was diagnosed with stage 2 breast cancer and underwent chemotherapy which caused anemia; her oncologist prescribed Aranesp to treat the chemotherapy-induced anemia, which helped Dimitra maintain her energy levels to care for her family and keep up with her daily activities during cancer treatment. The document discusses Amgen's research, development, and delivery of biotechnology medicines to treat serious illnesses like cancer, and highlights one patient's experience using the anemia treatment Aranesp during her breast cancer treatment.
2007 Q4 TRW Auto Earnings Presentation
TRW reported its financial results for the 4th quarter and full year of 2007. Key highlights include:
- Record sales of $14.7 billion for the full year, an increase of 11.9% over 2006.
- 4th quarter sales were $3.9 billion, an increase of 18.8% over the same period in 2006.
- Net earnings for the full year were $90 million, or $0.88 per share. Excluding one-time items, earnings were $2.28 per share.
- Guidance for 2008 expects sales between $15.6-16 billion and earnings per share between $2.15-2.45.
amgen Investors_2004_Proxy
The document is a letter from Kevin W. Sharer, Chairman and CEO of Amgen, inviting stockholders to Amgen's annual meeting on May 13, 2004. The letter summarizes that stockholders will vote on electing four directors, ratifying the selection of the independent auditors, and two stockholder proposals. It recommends voting for the nominees and ratification, and against the proposals. It also provides instructions for stockholders to obtain an admission ticket to attend the meeting.
amgen Investors_2005_Proxy
1. The document is a letter from Kevin W. Sharer, Chairman and CEO of Amgen Inc., informing stockholders about the upcoming Annual Meeting of Stockholders on May 11, 2005.
2. At the Annual Meeting, stockholders will vote on electing three directors, ratifying the selection of the independent accountants, and three stockholder proposals.
3. The Board recommends voting for the election of directors and ratification of the accountants, and against the three stockholder proposals. Stockholders are urged to vote by proxy, mail, internet or telephone in advance of the meeting.
chubb3671 Supplementary Investor Information
This document provides supplementary financial information for The Chubb Corporation for the quarter ending March 31, 2005. It includes:
- Consolidated balance sheet highlights showing total invested assets of $31.9 billion.
- Summaries of invested assets by corporate and property/casualty segments.
- Investment income after taxes for corporate and property/casualty segments.
- Property/casualty insurance group statutory surplus of $8.25 billion.
- Changes in net unpaid losses for various lines of business.
- Worldwide underwriting results by line of business, showing a total statutory underwriting income of $134.4 million.
chubb3902 Supplementary Investor Information
The document provides supplementary investor information from The Chubb Corporation as of June 30, 2005. It includes:
- Consolidated balance sheet highlights showing total invested assets of $32.9 billion including fixed maturities and equity securities.
- Summaries of invested assets for Chubb's Corporate and Property & Casualty segments totaling over $31 billion.
- Investment income after taxes for the second quarter and first half of 2005, with Property & Casualty investment income of $261 million and $513 million respectively.
- Property & Casualty underwriting results for the second quarter and first half of 2005, including a $4.3 billion statutory policyholders' surplus for the P
Supplementary Investor Information Y13880_Edgar_992_0333_
The document provides supplementary investor information for The Chubb Corporation for the third quarter of 2005, including:
1) Consolidated balance sheet highlights and summaries of invested assets for both corporate and property/casualty segments.
2) Property/casualty underwriting results for the first nine months of 2005, showing a statutory underwriting income of $293.6 million.
3) Details of changes in net unpaid losses and the estimated impact of catastrophes including Hurricane Katrina of $511 million pre-tax cost.
sup2006 01/31 Supplementary Investor Information
The document provides supplementary investor information for The Chubb Corporation as of December 31, 2005. It includes a consolidated balance sheet, details on share repurchase activity, summaries of invested assets and investment income for both corporate and property & casualty segments. It also provides property & casualty underwriting results for 2005 and 2004, including net premiums written and earned, losses incurred and expenses by line of business.
chubb 5042 Supplementary Investor Information
This document provides supplementary financial information for The Chubb Corporation as of March 31, 2006. It includes consolidated balance sheet highlights, share repurchase activity, summaries of invested assets for corporate and property & casualty segments, investment income after taxes, statutory policyholders' surplus, changes in net unpaid losses, and underwriting results for personal, commercial, and specialty insurance lines of business. Key metrics such as loss ratios, expense ratios, and combined ratios are also presented.
chubb 5264 Supplementary Investor Information
This document provides supplementary investor information from The Chubb Corporation for the period ending June 30, 2006. It includes consolidated balance sheet highlights, share repurchase activity, summaries of invested assets, investment income after taxes, statutory policyholders' surplus, changes in net unpaid losses, and underwriting results by line of business for year-to-date and quarterly periods. Key metrics such as loss ratios, expense ratios, and combined ratios are presented.
chubb 5925 Supplementary Investor Information
The document provides financial information for The Chubb Corporation as of September 30, 2006. It includes highlights of consolidated balance sheet items, share repurchase activity, summaries of invested assets and investment income for both corporate and property/casualty segments. Details are also given on property/casualty underwriting results for various lines of business on a year-to-date and quarterly basis, including ratios and comparisons to prior periods. Key terms are defined at the end.
chubb6 186 Supplementary Investor Information
This document provides supplementary investor information from The Chubb Corporation for the period ending December 31, 2006. It includes highlights of consolidated balance sheet items, summaries of invested assets, investment income after taxes, statutory policyholders' surplus, changes in unpaid losses, and worldwide property and casualty underwriting results for 2006 and 2005. Specifically, total invested assets increased to $37.7 billion in 2006 from $34.6 billion in 2005. Net income after taxes from investments was $1.2 billion for property and casualty in 2006. Statutory policyholders' surplus grew to $11.3 billion in 2006 from $8.9 billion in 2005.
chubb 6776 Supplementary Investor Information
This document provides a summary of financial information for The Chubb Corporation as of March 31, 2007. Some key highlights include:
- Total invested assets were $38.7 billion as of March 31, 2007, with fixed maturities making up the majority.
- Statutory policyholders' surplus for Chubb's property and casualty insurance group was estimated at $11.95 billion as of March 31, 2007, with a ratio of statutory net premiums written to surplus of 1.00 to 1.
- For the three months ended March 31, 2007, Chubb's worldwide property and casualty underwriting results showed a total underwriting income of $202 million for personal insurance and $144 million
chubb 7572 Supplementary Investor Information
This document provides supplementary investor information from The Chubb Corporation for the period ending June 30, 2007. It includes highlights of Chubb's consolidated balance sheet, share repurchase activity, summaries of invested assets for Corporate and Property & Casualty segments, and investment income after taxes. Key metrics provided are total invested assets of $39.5 billion, shareholders' equity of $13.8 billion, and year-to-date Property & Casualty investment income of $360 million.
chubb 7804 Supplementary Investor Information
This document provides supplementary investor information for The Chubb Corporation, including consolidated balance sheet highlights, share repurchase activity, summaries of invested assets, investment income after taxes, statutory policyholders' surplus, changes in net unpaid losses, and underwriting results for both the nine months and quarters ended September 30, 2007 and 2006. Key figures include total invested assets of $40.5 billion, shareholders' equity of $14.2 billion, and worldwide property and casualty underwriting income of $543 million for the nine months ended September 30, 2007.
More Related Content
Viewers also liked
amgen Investors_2003_AnnualReport
Amgen seeks to discover, develop, and commercialize proteins, antibodies, and small molecules to treat grievous illnesses through decades of scientific research. It pursues this mission through rigorous clinical testing of potential new therapeutics focused on areas like cancer, kidney disease, and neurodegenerative disorders. Amgen has extensive manufacturing operations worldwide to reliably supply its approved treatments to patients globally.
amgen Investors_2000_AnnualReport
This annual report summarizes Amgen's performance in 2000 and outlines goals for the future. Key points include:
- Amgen achieved strong financial results in 2000 and aims to more than double revenues and products on the market in the next five years.
- The company reaffirmed its commitment to its core values and adopted a shared aspiration to become the world's best human therapeutics company.
- Amgen hopes to launch four new products in the next 18 months, including ARANESP, anakinra, abarelix-depot, and SD/01, to treat conditions like anemia and cancer.
- The company expanded its R&D capabilities, grew its product pipeline, and plans to
amgen Investors_2002_AnnualReport
This annual report summarizes Amgen's performance and achievements in 2002. Some key points:
- Amgen served more patients than ever before and launched several new potential blockbuster products. It also delivered strong financial results.
- A major accomplishment was gaining FDA approval for its new ENBREL manufacturing facility in Rhode Island. This relieved a supply shortage and allowed more patients access to this important drug to treat rheumatoid arthritis.
- Amgen combined with Immunex Corporation, advancing scientific programs, bringing organizations together, and filling key roles. Construction also advanced on new research and manufacturing facilities.
- Despite significant growth, Amgen remained focused on its core values of being science-based, creating value for
2005 Q2 TRW Auto Earnings Presentation
TRW Automotive reported second quarter 2005 financial results. Key highlights include:
- Sales increased 6% to $3.4 billion compared to the prior year, driven by new product sales and currency effects.
- Net earnings were $85 million or $0.83 per share, which included a one-time $17 million tax benefit. Excluding this, earnings were $75 million or $0.73 per share.
- EBITDA was $324 million, roughly flat with the prior year after adjusting for restructuring charges.
- The company provided an updated outlook for 2005 with revenue of $12.5-12.9 billion and EPS of $1.60-1.80, excluding
amgen Investors_2005_AnnualReport
Dimitra, a 48-year-old mother of 3, was diagnosed with stage 2 breast cancer and underwent chemotherapy which caused anemia; her oncologist prescribed Aranesp to treat the chemotherapy-induced anemia, which helped Dimitra maintain her energy levels to care for her family and keep up with her daily activities during cancer treatment. The document discusses Amgen's research, development, and delivery of biotechnology medicines to treat serious illnesses like cancer, and highlights one patient's experience using the anemia treatment Aranesp during her breast cancer treatment.
2007 Q4 TRW Auto Earnings Presentation
TRW reported its financial results for the 4th quarter and full year of 2007. Key highlights include:
- Record sales of $14.7 billion for the full year, an increase of 11.9% over 2006.
- 4th quarter sales were $3.9 billion, an increase of 18.8% over the same period in 2006.
- Net earnings for the full year were $90 million, or $0.88 per share. Excluding one-time items, earnings were $2.28 per share.
- Guidance for 2008 expects sales between $15.6-16 billion and earnings per share between $2.15-2.45.
amgen Investors_2004_Proxy
The document is a letter from Kevin W. Sharer, Chairman and CEO of Amgen, inviting stockholders to Amgen's annual meeting on May 13, 2004. The letter summarizes that stockholders will vote on electing four directors, ratifying the selection of the independent auditors, and two stockholder proposals. It recommends voting for the nominees and ratification, and against the proposals. It also provides instructions for stockholders to obtain an admission ticket to attend the meeting.
amgen Investors_2005_Proxy
1. The document is a letter from Kevin W. Sharer, Chairman and CEO of Amgen Inc., informing stockholders about the upcoming Annual Meeting of Stockholders on May 11, 2005.
2. At the Annual Meeting, stockholders will vote on electing three directors, ratifying the selection of the independent accountants, and three stockholder proposals.
3. The Board recommends voting for the election of directors and ratification of the accountants, and against the three stockholder proposals. Stockholders are urged to vote by proxy, mail, internet or telephone in advance of the meeting.
Viewers also liked (11)
More from finance18
chubb3671 Supplementary Investor Information
This document provides supplementary financial information for The Chubb Corporation for the quarter ending March 31, 2005. It includes:
- Consolidated balance sheet highlights showing total invested assets of $31.9 billion.
- Summaries of invested assets by corporate and property/casualty segments.
- Investment income after taxes for corporate and property/casualty segments.
- Property/casualty insurance group statutory surplus of $8.25 billion.
- Changes in net unpaid losses for various lines of business.
- Worldwide underwriting results by line of business, showing a total statutory underwriting income of $134.4 million.
chubb3902 Supplementary Investor Information
The document provides supplementary investor information from The Chubb Corporation as of June 30, 2005. It includes:
- Consolidated balance sheet highlights showing total invested assets of $32.9 billion including fixed maturities and equity securities.
- Summaries of invested assets for Chubb's Corporate and Property & Casualty segments totaling over $31 billion.
- Investment income after taxes for the second quarter and first half of 2005, with Property & Casualty investment income of $261 million and $513 million respectively.
- Property & Casualty underwriting results for the second quarter and first half of 2005, including a $4.3 billion statutory policyholders' surplus for the P
Supplementary Investor Information Y13880_Edgar_992_0333_
The document provides supplementary investor information for The Chubb Corporation for the third quarter of 2005, including:
1) Consolidated balance sheet highlights and summaries of invested assets for both corporate and property/casualty segments.
2) Property/casualty underwriting results for the first nine months of 2005, showing a statutory underwriting income of $293.6 million.
3) Details of changes in net unpaid losses and the estimated impact of catastrophes including Hurricane Katrina of $511 million pre-tax cost.
sup2006 01/31 Supplementary Investor Information
The document provides supplementary investor information for The Chubb Corporation as of December 31, 2005. It includes a consolidated balance sheet, details on share repurchase activity, summaries of invested assets and investment income for both corporate and property & casualty segments. It also provides property & casualty underwriting results for 2005 and 2004, including net premiums written and earned, losses incurred and expenses by line of business.
chubb 5042 Supplementary Investor Information
This document provides supplementary financial information for The Chubb Corporation as of March 31, 2006. It includes consolidated balance sheet highlights, share repurchase activity, summaries of invested assets for corporate and property & casualty segments, investment income after taxes, statutory policyholders' surplus, changes in net unpaid losses, and underwriting results for personal, commercial, and specialty insurance lines of business. Key metrics such as loss ratios, expense ratios, and combined ratios are also presented.
chubb 5264 Supplementary Investor Information
This document provides supplementary investor information from The Chubb Corporation for the period ending June 30, 2006. It includes consolidated balance sheet highlights, share repurchase activity, summaries of invested assets, investment income after taxes, statutory policyholders' surplus, changes in net unpaid losses, and underwriting results by line of business for year-to-date and quarterly periods. Key metrics such as loss ratios, expense ratios, and combined ratios are presented.
chubb 5925 Supplementary Investor Information
The document provides financial information for The Chubb Corporation as of September 30, 2006. It includes highlights of consolidated balance sheet items, share repurchase activity, summaries of invested assets and investment income for both corporate and property/casualty segments. Details are also given on property/casualty underwriting results for various lines of business on a year-to-date and quarterly basis, including ratios and comparisons to prior periods. Key terms are defined at the end.
chubb6 186 Supplementary Investor Information
This document provides supplementary investor information from The Chubb Corporation for the period ending December 31, 2006. It includes highlights of consolidated balance sheet items, summaries of invested assets, investment income after taxes, statutory policyholders' surplus, changes in unpaid losses, and worldwide property and casualty underwriting results for 2006 and 2005. Specifically, total invested assets increased to $37.7 billion in 2006 from $34.6 billion in 2005. Net income after taxes from investments was $1.2 billion for property and casualty in 2006. Statutory policyholders' surplus grew to $11.3 billion in 2006 from $8.9 billion in 2005.
chubb 6776 Supplementary Investor Information
This document provides a summary of financial information for The Chubb Corporation as of March 31, 2007. Some key highlights include:
- Total invested assets were $38.7 billion as of March 31, 2007, with fixed maturities making up the majority.
- Statutory policyholders' surplus for Chubb's property and casualty insurance group was estimated at $11.95 billion as of March 31, 2007, with a ratio of statutory net premiums written to surplus of 1.00 to 1.
- For the three months ended March 31, 2007, Chubb's worldwide property and casualty underwriting results showed a total underwriting income of $202 million for personal insurance and $144 million
chubb 7572 Supplementary Investor Information
This document provides supplementary investor information from The Chubb Corporation for the period ending June 30, 2007. It includes highlights of Chubb's consolidated balance sheet, share repurchase activity, summaries of invested assets for Corporate and Property & Casualty segments, and investment income after taxes. Key metrics provided are total invested assets of $39.5 billion, shareholders' equity of $13.8 billion, and year-to-date Property & Casualty investment income of $360 million.
chubb 7804 Supplementary Investor Information
This document provides supplementary investor information for The Chubb Corporation, including consolidated balance sheet highlights, share repurchase activity, summaries of invested assets, investment income after taxes, statutory policyholders' surplus, changes in net unpaid losses, and underwriting results for both the nine months and quarters ended September 30, 2007 and 2006. Key figures include total invested assets of $40.5 billion, shareholders' equity of $14.2 billion, and worldwide property and casualty underwriting income of $543 million for the nine months ended September 30, 2007.
chubb 8085 Supplementary Investor Information
This document provides supplementary financial information for The Chubb Corporation as of December 31, 2007. It includes highlights of consolidated balance sheets, share repurchase activity, summaries of invested assets, investment income after taxes for corporate and property/casualty divisions, statutory policyholder surplus, changes in unpaid losses, and underwriting results by line of business for 2007 and 2006.
chubb 8922 Supplementary Investor Information
This document provides financial information about Chubb Corporation's property and casualty underwriting results for 2007 and 2006. It summarizes key metrics like net premiums written, losses incurred, expenses incurred, underwriting income, and combined loss/expense ratios for different business lines including personal, commercial, and specialty insurance. It also notes that beginning in 2008, foreign currency fluctuations will be accounted for differently in the reporting of losses paid and outstanding losses. Overall underwriting income increased from $1.886 billion to $2.064 billion from 2006 to 2007.
chubb 8399 Supplementary Investor Information
The document provides supplementary financial information for Chubb Corporation as of March 31, 2008. Key highlights include:
- Total invested assets were $40.1 billion, with fixed maturities making up the majority.
- Statutory policyholders' surplus for property and casualty insurance was estimated at $13.3 billion, with a ratio of net premiums written to surplus of 0.9 to 1.
- For the three months ended March 31, 2008, worldwide underwriting resulted in a total profit of $138 million for commercial lines and $164 million for personal lines. Loss and expense ratios remained high but stable.
chubb 8921 Supplementary Investor Information
The document is a report from The Chubb Corporation detailing changes to how losses are presented in their property and casualty underwriting results. Specifically, beginning in Q3 2008, foreign currency fluctuations will impact "net losses paid" and "increase (decrease) in outstanding losses" differently than before. The report provides definitions, ratios, and quarterly underwriting results for Q1 2008 and 2007 to reflect these presentation modifications. Incurred losses remain unchanged.
chubb 8576 Supplementary Investor Information
This document provides supplementary investor information from The Chubb Corporation, including:
- Consolidated balance sheet highlights and share repurchase activity as of June 30, 2008.
- Summaries of invested assets for Corporate and Property & Casualty segments.
- Investment income after taxes for Corporate and Property & Casualty segments for the second quarter and first six months of 2008 versus 2007.
- Property & Casualty statutory policyholders' surplus, change in net unpaid losses, and underwriting results by line of business for the first half of 2008 versus the same period in 2007.
chubb 8918 Supplementary Investor Information
This document from Chubb Corporation reports modifications to the presentation of losses incurred in property and casualty underwriting results for the six months ended June 30, 2008 and 2007. Specifically, it notes that beginning in Q3 2008, foreign currency fluctuations will be reflected differently in "net losses paid" and "increase (decrease) in outstanding losses", though incurred losses remain unchanged. It provides definitions of key terms like underwriting income/loss and combined loss/expense ratio used to evaluate underwriting performance. The document then presents detailed underwriting results by line of business and geographic region.
chubb Supplementary Investor Information8917
This document provides supplementary investor information from The Chubb Corporation for the quarter ending September 30, 2008. It includes a consolidated balance sheet, share repurchase activity, summaries of invested assets for corporate and property & casualty divisions, and investment income and underwriting results. Beginning in Q3 2008, foreign currency fluctuations will impact property & casualty loss reporting differently than in the past.
chubb Supplementary Investor Information9489
This document provides supplementary financial information for The Chubb Corporation as of December 31, 2008. It includes highlights of the consolidated balance sheet, share repurchase activity, summaries of invested assets for the Corporate and Property and Casualty segments, and investment income. It also contains information on statutory policyholders' surplus, changes in unpaid losses, and underwriting results for year-to-date and quarterly periods for the Property and Casualty Insurance Group. Key terms are defined at the end.
More from finance18 (20)
Supplementary Investor Information Y13880_Edgar_992_0333_
Supplementary Investor Information Y13880_Edgar_992_0333_
Recently uploaded
The state of welfare Resolution Foundation Event
How has Britain’s safety net changed since 2010 and what comes next?
What Lessons Can New Investors Learn from Newman Leech’s Success?
Newman Leech's success in the real estate industry is based on key lessons and principles, offering practical advice for new investors and serving as a blueprint for building a successful career.
快速办理(RWTH毕业证书)德国亚琛工业大学毕业证录取通知书一模一样
原件一模一样【微信：bwp0011】《(RWTH毕业证书)德国亚琛工业大学毕业证》【微信：bwp0011】学位证，留信认证（真实可查，永久存档）原件一模一样纸张工艺/offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原。
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问微bwp0011
【主营项目】
一.毕业证【微bwp0011】成绩单、使馆认证、教育部认证、雅思托福成绩单、学生卡等！
二.真实使馆公证(即留学回国人员证明,不成功不收费)
三.真实教育部学历学位认证（教育部存档！教育部留服网站永久可查）
四.办理各国各大学文凭(一对一专业服务,可全程监控跟踪进度)
如果您处于以下几种情况：
◇在校期间，因各种原因未能顺利毕业……拿不到官方毕业证【微bwp0011】
◇面对父母的压力，希望尽快拿到；
◇不清楚认证流程以及材料该如何准备；
◇回国时间很长，忘记办理；
◇回国马上就要找工作，办给用人单位看；
◇企事业单位必须要求办理的
◇需要报考公务员、购买免税车、落转户口
◇申请留学生创业基金
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
Economic trends from a business point of view (May 2024)
Economic trends from a business point of view (May 2024)Інститут економічних досліджень та політичних консультацій
“Amidst Tempered Optimism” Main economic trends in May 2024 based on the results of the New Monthly Enterprises Survey, #NRES
On 12 June 2024 the Institute for Economic Research and Policy Consulting (IER) held an online event “Economic Trends from a Business Perspective (May 2024)”.
During the event, the results of the 25-th monthly survey of business executives “Ukrainian Business during the war”, which was conducted in May 2024, were presented.
The field stage of the 25-th wave lasted from May 20 to May 31, 2024. In May, 532 companies were surveyed.
The enterprise managers compared the work results in May 2024 with April, assessed the indicators at the time of the survey (May 2024), and gave forecasts for the next two, three, or six months, depending on the question. In certain issues (where indicated), the work results were compared with the pre-war period (before February 24, 2022).
✅ More survey results in the presentation.
✅ Video presentation: https://youtu.be/4ZvsSKd1MzE
Navigating Your Financial Future: Comprehensive Planning with Mike Baumann
Learn how financial planner Mike Baumann helps individuals and families articulate their financial aspirations and develop tailored plans. This presentation delves into budgeting, investment strategies, retirement planning, tax optimization, and the importance of ongoing plan adjustments.
真实可查(nwu毕业证书)美国西北大学毕业证学位证书范本原版一模一样
原版定制【微信:bwp0011】《(nwu毕业证书)美国西北大学毕业证学位证书》【微信:bwp0011】成绩单 、雅思、外壳、留信学历认证永久存档查询，采用学校原版纸张、特殊工艺完全按照原版一比一制作（包括：隐形水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠，文字图案浮雕，激光镭射，紫外荧光，温感，复印防伪）行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备，十五年致力于帮助留学生解决难题，业务范围有加拿大、英国、澳洲、韩国、美国、新加坡，新西兰等学历材料，包您满意。
【业务选择办理准则】
一、工作未确定，回国需先给父母、亲戚朋友看下文凭的情况，办理一份就读学校的毕业证【微信bwp0011】文凭即可
二、回国进私企、外企、自己做生意的情况，这些单位是不查询毕业证真伪的，而且国内没有渠道去查询国外文凭的真假，也不需要提供真实教育部认证。鉴于此，办理一份毕业证【微信bwp0011】即可
三、进国企，银行，事业单位，考公务员等等，这些单位是必需要提供真实教育部认证的，办理教育部认证所需资料众多且烦琐，所有材料您都必须提供原件，我们凭借丰富的经验，快捷的绿色通道帮您快速整合材料，让您少走弯路。
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
【关于价格问题（保证一手价格）】
我们所定的价格是非常合理的，而且我们现在做得单子大多数都是代理和回头客户介绍的所以一般现在有新的单子 我给客户的都是第一手的代理价格，因为我想坦诚对待大家 不想跟大家在价格方面浪费时间
对于老客户或者被老客户介绍过来的朋友，我们都会适当给一些优惠。
TechnoXander Confirmation of Payee Product Pack 1.pdf
Confirmation of Payee (CoP) is a vital security measure adopted by financial institutions and payment service providers. Its core purpose is to confirm that the recipient’s name matches the information provided by the sender during a banking transaction, ensuring that funds are transferred to the correct payment account.
Confirmation of Payee was built to tackle the increasing numbers of APP Fraud and in the landscape of UK banking, the spectre of APP fraud looms large. In 2022, over £1.2 billion was stolen by fraudsters through authorised and unauthorised fraud, equivalent to more than £2,300 every minute. This statistic emphasises the urgent need for robust security measures like CoP. While over £1.2 billion was stolen through fraud in 2022, there was an eight per cent reduction compared to 2021 which highlights the positive outcomes obtained from the implementation of Confirmation of Payee. The number of fraud cases across the UK also decreased by four per cent to nearly three million cases during the same period; latest statistics from UK Finance.
In essence, Confirmation of Payee plays a pivotal role in digital banking, guaranteeing the flawless execution of banking transactions. It stands as a guardian against fraud and misallocation, demonstrating the commitment of financial institutions to safeguard their clients’ assets. The next time you engage in a banking transaction, remember the invaluable role of CoP in ensuring the security of your financial interests.
For more details, you can visit https://technoxander.com.
Seeman_Fiintouch_LLP_Newsletter_Jun_2024.pdf
The Impact of the 2024 Indian
Election Beyond Borders
01. Investment Gyan
02. Market Update
03. Inspiration investment story
How to Invest in Cryptocurrency for Beginners: A Complete Guide
Cryptocurrency is digital money that operates independently of a central authority, utilizing cryptography for security. Unlike traditional currencies issued by governments (fiat currencies), cryptocurrencies are decentralized and typically operate on a technology called blockchain. Each cryptocurrency transaction is recorded on a public ledger, ensuring transparency and security.
Cryptocurrencies can be used for various purposes, including online purchases, investment opportunities, and as a means of transferring value globally without the need for intermediaries like banks.
Understanding-Stocks-and-Real-Estate.pptx
Explore the world of investments with an in-depth comparison of the stock market and real estate. Understand their fundamentals, risks, returns, and diversification strategies to make informed financial decisions that align with your goals.
Fabular Frames and the Four Ratio Problem
Digital, interactive art showing the struggle of a society in providing for its present population while also saving planetary resources for future generations. Spread across several frames, the art is actually the rendering of real and speculative data. The stereographic projections change shape in response to prompts and provocations. Visitors interact with the model through speculative statements about how to increase savings across communities, regions, ecosystems and environments. Their fabulations combined with random noise, i.e. factors beyond control, have a dramatic effect on the societal transition. Things get better. Things get worse. The aim is to give visitors a new grasp and feel of the ongoing struggles in democracies around the world.
Stunning art in the small multiples format brings out the spatiotemporal nature of societal transitions, against backdrop issues such as energy, housing, waste, farmland and forest. In each frame we see hopeful and frightful interplays between spending and saving. Problems emerge when one of the two parts of the existential anaglyph rapidly shrinks like Arctic ice, as factors cross thresholds. Ecological wealth and intergenerational equity areFour at stake. Not enough spending could mean economic stress, social unrest and political conflict. Not enough saving and there will be climate breakdown and ‘bankruptcy’. So where does speculative design start and the gambling and betting end? Behind each fabular frame is a four ratio problem. Each ratio reflects the level of sacrifice and self-restraint a society is willing to accept, against promises of prosperity and freedom. Some values seem to stabilise a frame while others cause collapse. Get the ratios right and we can have it all. Get them wrong and things get more desperate.
Calculation of compliance cost: Veterinary and sanitary control of aquatic bi...
Calculation of compliance cost in the fishing industry of Russia after extended SCM model (Veterinary and sanitary control of aquatic biological resources (ABR) - Preparation of documents, passing expertise)
KYC Compliance: A Cornerstone of Global Crypto Regulatory Frameworks
This presentation explores the pivotal role of KYC compliance in shaping and enforcing global regulations within the dynamic landscape of cryptocurrencies. Dive into the intricate connection between KYC practices and the evolving legal frameworks governing the crypto industry.
Recently uploaded (20)
What Lessons Can New Investors Learn from Newman Leech’s Success?
What Lessons Can New Investors Learn from Newman Leech’s Success?
Economic trends from a business point of view (May 2024)
Economic trends from a business point of view (May 2024)
Navigating Your Financial Future: Comprehensive Planning with Mike Baumann
Navigating Your Financial Future: Comprehensive Planning with Mike Baumann
TechnoXander Confirmation of Payee Product Pack 1.pdf
TechnoXander Confirmation of Payee Product Pack 1.pdf
How to Invest in Cryptocurrency for Beginners: A Complete Guide
How to Invest in Cryptocurrency for Beginners: A Complete Guide
Importance of community participation in development projects.pdf
Importance of community participation in development projects.pdf
Calculation of compliance cost: Veterinary and sanitary control of aquatic bi...
Calculation of compliance cost: Veterinary and sanitary control of aquatic bi...
KYC Compliance: A Cornerstone of Global Crypto Regulatory Frameworks
KYC Compliance: A Cornerstone of Global Crypto Regulatory Frameworks